Biodesix, Inc. (BDSX)
23.66
-1.05
(-4.25%)
USD |
NASDAQ |
Oct 16, 16:00
23.56
-0.10
(-0.42%)
After-Hours: 20:00
Biodesix Research and Development Expense (Annual) : 12.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 12.00M |
| December 31, 2024 | 9.559M |
| December 31, 2023 | 9.988M |
| December 31, 2022 | 13.10M |
| Date | Value |
|---|---|
| December 31, 2021 | 12.79M |
| December 31, 2020 | 10.82M |
| December 31, 2019 | 10.47M |
| December 31, 2018 | 8.188M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Quest Diagnostics, Inc. | -- |
| Labcorp Holdings, Inc. | -- |
| OPKO Health, Inc. | 124.03M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 37.08M |